image
Immunovant, Inc. IMVT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 16.635
4.43 %
$ 2.84 B
Market Cap
-5.87
P/E
Price Target Average
203.58%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
14.87%
Net Income Estimate
27.29%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Immunovant, Inc.
image
Wall Street analysts predict an average 1-year price target for IMVT of $50.5 , with forecasts ranging from a low of $46 to a high of $57 .
IMVT Lowest Price Target Wall Street Target
46 USD 176.53%
IMVT Average Price Target Wall Street Target
50.5 USD 203.58%
IMVT Highest Price Target Wall Street Target
57 USD 242.65%
Price
Max Price Target
Min Price Target
Average Price Target
60605555505045454040353530302525202015151010Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26
REVENUE FORECAST

Revenue Forecast Chart IMVT

image
$1.8b$1.8b$1.6b$1.6b$1.4b$1.4b$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.020242024202520252026202620272027202820282029202920302030
EBIT FORECAST

EBIT Forecast Chart IMVT

image
$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)20242024202520252026202620272027202820282029202920302030
NET INCOME FORECAST

Net Income Chart IMVT

image
$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)20242024202520252026202620272027202820282029202920302030